Similar articles

• Alzheimer's disease: the role of tacrine therapy.

  Jogerst G. Jogerst G. Iowa Med. 1995 Oct;85(10):409-11. Iowa Med. 1995. PMID: 7591656 Review. No abstract available.
• [Clinical study of patients with Alzheimer's disease under treatment with tacrine].

  García-López MT, Guardado-Santervás P. García-López MT, et al. Rev Neurol. 2001 Feb 16-28;32(4):394-7. Rev Neurol. 2001. PMID: 11398762 Clinical Trial. Spanish. No abstract available.
• Cholinergic delirium and neurotoxicity associated with tacrine for Alzheimer's dementia.

  Trzepacz PT, Ho V, Mallavarapu H. Trzepacz PT, et al. Psychosomatics. 1996 May-Jun;37(3):299-301. doi: 10.1016/S0033-3182(96)71569-4. Psychosomatics. 1996. PMID: 8849507 No abstract available.
• [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].

  Wallin A. Wallin A. Lakartidningen. 1996 Jan 3;93(1-2):22-4. Lakartidningen. 1996. PMID: 8544526 Swedish. No abstract available.
• [Tacrine in Alzheimer's disease].

  López de Munain A. López de Munain A. Rev Neurol. 1997 Jul;25 Suppl 1:S70-2. Rev Neurol. 1997. PMID: 9280671 Review. Spanish. No abstract available.